{"id":329061,"date":"2026-10-28T09:29:52","date_gmt":"2026-10-28T03:59:52","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/piramal-pharma-q2-results-fy27-pat-171-crore\/"},"modified":"2026-10-28T09:29:52","modified_gmt":"2026-10-28T03:59:52","slug":"piramal-pharma-q2-results-fy27-pat-171-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/piramal-pharma-q2-results-fy27-pat-171-crore\/","title":{"rendered":"Piramal Pharma Q2 Results FY27: Revenue Down 34.17% to Rs 1,345.38 Cr, PAT Rs 170.74 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Piramal Pharma Q2 Results FY27 were declared on 27 October 2026 and cover the July to September 2026 quarter on a standalone basis. Revenue fell 34.17% YoY to Rs 1,345.38 Cr, while the company moved to a net profit of Rs 170.74 Cr from a net loss of Rs 99.22 Cr a year earlier. These quarterly results show YoY growth in profit and a decline in revenue.<\/p>\n<\/div>\n

Piramal Pharma Ltd<\/a> (PPLPHARMA) Q2 Results FY27 announced on 27 October 2026, covering the company’s financial performance for the July to September quarter. The standalone results show revenue of Rs 1,345.38 Cr against Rs 2,043.72 Cr in the same quarter last year, and net profit of Rs 170.74 Cr against a net loss of Rs 99.22 Cr. Piramal Pharma Q2 Results FY27 therefore carry a results date of 27 October 2026 and show revenue below last year while net profit is above it.<\/p>\n

This results analysis of Piramal Pharma Q2 Results covers the financial highlights, the business drivers, the outlook and the risks. It starts with the Financial Highlights table that follows, which places revenue and net profit beside the same quarter of last year.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n